β-Adrenergic receptors mediate in vivo the adrenaline inhibition of lipopolysaccharide-induced tumor necrosis factor release
- 31 October 1993
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 38 (2), 127-130
- https://doi.org/10.1016/0165-2478(93)90177-4
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists.The Journal of Immunology, 1992
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- Tumor Necrosis Factor Modulates the Inactivation of Catecholamine Secretion in Cultured Sympathetic NeuronsJournal of Neurochemistry, 1992
- Modulation of interleukin-1 and tumor necrosis factor expression by ?-adrenergic agonists in mouse ameboid microglial cellsExperimental Brain Research, 1991
- The effect of norepinephrine on endotoxin-mediated macrophage activationJournal of Neuroimmunology, 1991
- Differential regulation of IL 6, IL 1 A, IL 1β and TNFα production in LPS-stimulated human monocytes: Role of cyclic AMPCytokine, 1990
- TUMOR NECROSIS, CACHEXIA, SHOCK, AND INFLAMMATION: A COMMON MEDIATORAnnual Review of Biochemistry, 1988
- Noradrenergic Sympathetic Neural Interactions with the Immune System: Structure and FunctionImmunological Reviews, 1987
- Beta-adrenergic receptors on human suppressor, helper, and cytolytic lymphocytesBiochemical Pharmacology, 1986
- ??- and ??-Adrenergic Receptor Subtypes Properties, Distribution and RegulationDrugs, 1984